In the case of dyslipidemia, the accumulated fat in the tissue extracellular mesenchyme reduces cellular sensitivity to insulin and triggers insulin resistance, leading to elevated blood glucose and HbA1c and the onset of type 2 DM [8]. This evidence concerns the gene INS and metabolic syndrome.